LASIK and multifocal IOLs superior to accommodative IOL for treating presbyopia

Article

PresbyLASIK or multifocal IOL implantation yield superior visual outcomes in patients with presbyopia, improving both near and distance vision, as opposed to accommodative IOL implantation, which improves distance vision only, according to a study published in the March 2008 issue of the Journal of Refractive Surgery.

PresbyLASIK or multifocal IOL implantation yield superior visual outcomes in patients with presbyopia, improving both near and distance vision, as opposed to accommodative IOL implantation, which improves distance vision only, according to a study published in the March 2008 issue of the Journal of Refractive Surgery.

Sudi Patel of the Vissum Instituto Oftalmológico de Alicante, Spain and researchers compared the visual outcomes of a multifocal IOL (Acri.Smart; Acri.Tec/Zeiss) and an accommodative lens (AT-45; Crystalens/Bausch & Lomb) for the correction of distance and near visual acuity (VA) with a LASIK procedure for presbyopia (presbyLASIK) and a control group fitted with a standard distance-correcting monofocal IOL (AcrySof; Alcon).

Distance and near decimal visual acuities were measured under similar conditions pre- and six months postoperatively in 45 patients (87 eyes). All acuity measures were standardized at 20 m (distance, projected chart) and 40 cm (near).

Preoperatively, the team recorded distance mean VAs of 0.15±0.21, 0.31±0.14, 0.35±0.15 and 0.32±0.18 for the Acri.Smart, AT-45, presbyLASIK and control groups, respectively. Postoperatively, this was 0.66±0.35, 0.68±0.28, 0.80±0.33 and 0.59±0.29 for each of the respective groups. In terms of near mean VAs, the team recorded preoperative figures of 0.13±0.21, 0.43±0.22, 0.15±0.20 and 0.40±0.29 for the Acri.Smart, AT-45, presbyLASIK and control groups, respectively. Postoperatively, this was 0.62±0.35, 0.51±0.27, 0.68±0.33 and 0.30±0.13 for each of the respective groups. Distance and near visual acuities improved significantly after surgery (p<0.05) except near acuities for the AT-45 IOL and control groups.

The study demonstrated that distance and near acuities improved with presbyLASIK and Acri.Smart IOLs when compared with monofocal IOLs. In those patients treated with the accommodative AT-45 IOL, average distance VA improved but not near VA.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.